Author:
Lacroix Jean Sébastien,Urena-Torres Pablo
Reference142 articles.
1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017
3. Current drug development challenges in chronic kidney disease (CKD) – identification of individualized determinants of renal progression and premature cardiovascular disease (CVD);Formentini;Nephrol Dial Transplant,2012
4. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease;Pollock;Kidney Int Suppl,2017
5. The number, quality, and coverage of randomized controlled trials in nephrology;Strippoli;J Am Soc Nephrol,2004
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献